Member Info for itshenderz

Another normal trading in the world of a Synairgen share holder, turn off your monitors and come back to it in a few weeks. (Easier said than done as I know I'll here 8am sharp in the morning)

Goodluck all.

Test of time....

Following on that point, I'd expect news of some substance in the next 2 trading weeks. This one included. Any later and regardless of research I fear the worst.

Not a negative, just a point.

My opinion

"Weren’t we supposed to be getting the hospital trial results in July??"

No we weren't.

And if we were, its only the 6th of the month.

Hope that answers your question.

Mamma mia, here we go again.

Hearing rumours of a buy out circa £1 a share.

Deals expected to land 1/4/21

All jokes aside, I got in here years ago at around 5/6p per, did very and sold my profits into the high teens. Was warned about getting back in at the drop and listened. Such a shame many genuine investors who had invested there hard earned money into this have turned there £ to dust. I remember one poster dedicating his entire life to it, presentations, his family savings, the lot.

If there's one thing anyone can takeaway from this and is reading here, its TAKE PROFITS when you can on AIM. Only a small % succeed, the games as b*nt as it comes.

My opinion only.

Good luck everyone on making some serious coins.

"The good news is HEMO aren't great at PR and they are not one of those companies the drip feed the market with mediocre RNS's"

This has to be a wind up surely?

The need for proven treatment continues, come on RM, deliver the goods.

https://amp.9news.com.au/article/cbda6c57-f937-4f6b-b0b7-670760fe8f1e

CW25 - Here's the direct link

https://www.morningstar.com/stocks/xlon/sng/ownership

Putting 2 and 2 together, perhaps they want Acacia to leave before any results are published. After all, directors, management team are going to want a big reward if there drug is proven successful.

Makes sense to me.

My opinion only.

Another one

RNS OUT

On the 31st March 2020 SNG confirmed commencement of dosing in trial of SNG001 in Covid-19. This way set in the hospital environment. 30th April 2020 SNG initiates dosing of SNG001 in the home environment, key factor... 75 of 100 in hospital have been dosed. Exactly 3/4. This is the part I'm extremely convinced about, I aren't a scientist by any means, and no data analyst either. But is it possible that after 3/4 of the patients dosed, you'd be able to have a good idea on how the treatment is going? Double blind or not, ward staff, nurses, feedback would give you a rough estimate on the success for sure. I personally don't believe the home environment is a 'trial' as such, maybe in title, but I can't see past the idea they've extended this to HELP patients on the given that its effective. Yes, full data needs to be draw out before any conclusion can be made, of course. The expansion... many presumed they weren't getting the numbers they wanted to fulfill the test, or could it have been with the effectiveness they have known from the 3/4 of hospital patients tested, it'd be a no brainer to help those infected with Covid-19 around the country? Its not all as it seems but there's just another way of looking at things.

Take from it what you will

Just my opinion as ever ;-)

Ghia - Just had that inkling, Friday/Mondays would be the best times to drop such news. I'm backing myself on this.

My opinion only ;-)

I'm gonna stick my head on the table and say results tomorrow morning.

Just that feeling

My opinion only, trusting my gut.

As I sit back now knowing my limitations and risk within this investment, as I have done for some time. I can safely watch the market do its trickery and not be perplexed by the games they're playing. Another day draws closer results, and soon us, majors, banks, media and more will be able to see exactly how good/bad treatment has been in COPD and Covid Patients within the hospital environment. Stick or twist.

In the words of jigsaw
"Its time to play the game"

All imvho

Goodluck Synairgeners ;-)

Market taking its toll as many realise the severity of this virus and treatment is needed. Simple as that.

Roll on the biggest month of Synairgens 15yr development.

All imvho

Good luck

As much as I agree with hitting the main stream media eg: BBC, Bloomberg etc, it seems that's just the way RM operates and we have to take that at face value. There's not a real lot he can say until the drug is proven to work in all fairness, it'd just be a repeat of the same used phrases and wait till results are in. He and everyone knows there's a chance SNG001 won't be as effective as one would like, and nothing would come across worse as blowing your trumpet across mainstream TV about this all singing all dancing treatment for it then to go to pot. Especially in a pandemic where thousands of people are dying and becoming infected. Conservative and professional up until a clear cut of data can be released, hes ticking all the boxes so far for me.

Each to there own.

All imvho.

Second wave, increased infection rate, R rate up etc, its merely going to effect the share price imo. You can have all the customers in the world but if you've not got the demand product.... its worthless. RM has been extremely conservative and rightfully so, he's a professional. Proof will be in the pudding this next coming month, I'd expect 80% of the picture to out and visible for everyone to see, that includes major holders / potential fundraising and partnerships. All successful , you're paying a heavy premier for a stake.

Roll on Monday.

All imvho

Nolupus,

COPD results are key for Synairgen and the development of the company, totally in agreement with that statement as its there primary target. Nevertheless, the pandemic/covid has brought out an alternate use for SNG001 and its arguable that 50/70 % of the current Mccap is due to this alone. COPD is a huge market, it is, there's estimated 3million people in the UK alone who are suffering and treatment is needed. However, for this too hold Hospital/Home trials need to work, and well. Its niave to think just COPD results alone will sustain this from falling, the market simply will not take anything other than success from all 3. I initially thought we would rise before results, as did many, but the odds are stacked against SNG here. 40p imo seems to be about right considering where we're at. All boxes have been ticked by the bod (questionable placing lock in agreement as its caused downward selling pressure) besides that I cannot fault. What we're all awaiting now is that clear cut data delivered from RM himself. The research, the timing, the calibre of the management team, everything adds up to me, hence why I'm buying the story. Its important to understand the upside here is also as massive as the potential downside. SNG have to effectively win against the odds here. I'm backing them all the way....

All imvho

Have a good weekend all

Been invested here for a while now, granted not as long as others but enough to understand the gist of what's occurring. As trail results draw closer, and the possibility of striking gold, (metaphorically speaking) is in sight the team in my opinion have to nail the first lot of results in next month. COPD is a huge market none the less, but many are here for the role Synairgen plays with tackling covid. I believe for this really take off the data from hospital patients NEEDS and I stress NEEDS to be good. An RNS along the lines off 'The company found excellent results testing SNG001 in covid patients in hospital patients'. Anything else, even 'some positives were taken' etc etc just won't cut it and the share price will drop. If the hosptial results are good many will suspect the home testing will be good and vice versa, hence the reason to nail the firsts.

Just my take on things, a big gamble for a big reward, I've weighed out the pros and cons and I'm in for the foreseeable.

Pays your money....

All imvho

Good luck